| Effect of coronavirus disease 2019 (COVID‐19) on maternal, perinatal and neonatal outcome: systematic review J Juan, MM Gil, Z Rong, Y Zhang, H Yang, LC Poon Ultrasound in Obstetrics & Gynecology 56 (1), 15-27, 2020 | 814 | 2020 |
| Analysis of cell‐free DNA in maternal blood in screening for fetal aneuploidies: updated meta‐analysis MM Gil, MS Quezada, R Revello, R Akolekar, KH Nicolaides Ultrasound in obstetrics & gynecology 45 (3), 249-266, 2015 | 725 | 2015 |
| Analysis of cell‐free DNA in maternal blood in screening for aneuploidies: updated meta‐analysis MM Gil, V Accurti, B Santacruz, MN Plana, KH Nicolaides Ultrasound in Obstetrics & Gynecology 50 (3), 302-314, 2017 | 688 | 2017 |
| Validation of targeted sequencing of single‐nucleotide polymorphisms for non‐invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y KH Nicolaides, A Syngelaki, M Gil, V Atanasova, D Markova Prenatal diagnosis 33 (6), 575-579, 2013 | 370 | 2013 |
| Implementation of maternal blood cell‐free DNA testing in early screening for aneuploidies MM Gil, MS Quezada, B Bregant, M Ferraro, KH Nicolaides Ultrasound in Obstetrics & Gynecology 42 (1), 34-40, 2013 | 209 | 2013 |
| Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis MM Gil, R Akolekar, MS Quezada, B Bregant, KH Nicolaides Fetal diagnosis and therapy 35 (3), 156-173, 2014 | 200 | 2014 |
| Prenatal detection of fetal triploidy from cell-free DNA testing in maternal blood KH Nicolaides, A Syngelaki, MM Gil, MS Quezada, Y Zinevich Fetal diagnosis and therapy 35 (3), 212-217, 2014 | 198 | 2014 |
| Performance of screening for aneuploidies by cell‐free DNA analysis of maternal blood in twin pregnancies E Bevilacqua, MM Gil, KH Nicolaides, E Ordoñez, V Cirigliano, H Dierickx, ... Ultrasound in Obstetrics & Gynecology 45 (1), 61-66, 2015 | 166 | 2015 |
| Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell‐free DNA test contingent on results from first‐trimester combined test MM Gil, R Revello, LC Poon, R Akolekar, KH Nicolaides Ultrasound in Obstetrics & Gynecology 47 (1), 45-52, 2016 | 162 | 2016 |
| Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta‐analysis MM Gil, S Galeva, J Jani, L Konstantinidou, R Akolekar, MN Plana, ... Ultrasound in Obstetrics & Gynecology 53 (6), 734-742, 2019 | 152 | 2019 |
| First‐trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell‐free DNA testing KH Nicolaides, D Wright, LC Poon, A Syngelaki, MM Gil Ultrasound in Obstetrics & Gynecology 42 (1), 41-50, 2013 | 146 | 2013 |
| Screening for trisomies 21, 18 and 13 by cell‐free DNA analysis of maternal blood at 10–11 weeks' gestation and the combined test at 11–13 weeks MS Quezada, MM Gil, C Francisco, G Orosz, KH Nicolaides Ultrasound in Obstetrics & Gynecology 45 (1), 36-41, 2015 | 144 | 2015 |
| Cell-free DNA analysis for trisomy risk assessment in first-trimester twin pregnancies MM Gil, MS Quezada, B Bregant, A Syngelaki, KH Nicolaides Fetal diagnosis and therapy 35 (3), 204-211, 2014 | 127 | 2014 |
| Assessment of fetal sex chromosome aneuploidy using directed cell-free DNA analysis KH Nicolaides, TJ Musci, CA Struble, A Syngelaki, MM Gil Fetal diagnosis and therapy 35 (1), 1-6, 2014 | 113 | 2014 |
| Pravastatin versus placebo in pregnancies at high risk of term preeclampsia M Döbert, AN Varouxaki, AC Mu, A Syngelaki, A Ciobanu, R Akolekar, ... Circulation 144 (9), 670-679, 2021 | 95 | 2021 |
| First‐trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure S Galeva, MM Gil, L Konstantinidou, R Akolekar, KH Nicolaides Ultrasound in Obstetrics & Gynecology 53 (6), 804-809, 2019 | 90 | 2019 |
| Use of intrapartum ultrasound in the prediction of complicated operative forceps delivery of fetuses in non‐occiput posterior position MJ Cuerva, C Bamberg, P Tobias, MM Gil, M De La Calle, JL Bartha Ultrasound in Obstetrics & Gynecology 43 (6), 687-692, 2014 | 90 | 2014 |
| First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing KH Nicolaides, A Syngelaki, LC Poon, MM Gil, D Wright Fetal diagnosis and therapy 35 (3), 185-192, 2014 | 88 | 2014 |
| Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis ER Smith, E Oakley, GW Grandner, K Ferguson, F Farooq, Y Afshar, ... BMJ global health 8 (1), e009495, 2023 | 87 | 2023 |
| Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis ER Smith, E Oakley, GW Grandner, G Rukundo, F Farooq, K Ferguson, ... American journal of obstetrics and gynecology 228 (2), 161-177, 2023 | 84 | 2023 |
